The values ​​right now comply with the Paris Inventory Change

Argan has signed an impact loan agreement with Crdit Agricole Nord de France and other Caisses Régionales de Crdit Agricole for EUR 139.6 million, the rate of which varies depending on the CSR (Corporate Social Responsibility) group’s performance. It will be measured by the development of two criteria: the percentage of BREEAM-certified development “very good” and the percentage of warehouse development “Aut0nom”.

DBV Technologies
DBV Technologies announced the positive results of a Phase 3 study conducted with Viaskin Peanut in children aged 1 to 3 years with peanut allergy. 67% of the subjects in the Viaskin Peanut group responded to treatment after 12 months, compared with 33.5% of the subjects in the placebo group. The pivotal study met its primary endpoint. The safety results were generally consistent with the Viaskin Peanut safety profile observed in previous clinical trials in peanut allergy children 4 years of age and older.

Stemcis, a Hybrigenics subsidiary specializing in the treatment of adipose tissue, mesenchymal stem cells and their use in plastic and reconstructive surgery, enters the US market, which took place from 3 to 5 June in Paris at the Palais des Congrès, Stemcis and the American company Overnia has entered into an exclusive distribution agreement.

GTT was chosen by its partner, the Korean shipyard Hyundai Samho Heavy Industries, to design the LNG tanks of a new LNG carrier on behalf of the Asian shipowner. GTT will design the tanks of this LNG carrier, which will offer a total cargo capacity of 174,000 m3 and will include the Mark III Flex membrane system developed by GTT. Delivery of the vessel is scheduled for the fourth quarter of 2025.

Pernod Ricard
Pernod Ricard is organizing its Capital Markets Day 2022 in Paris today. On this occasion, the group will present the implementation of its Conviviality platform, a new phase of the Transform & Accelerate strategic plan covering the financial years 2022/23 to 2024/25. The Conviviality platform allows you to optimize the potential of your brand portfolio and unique distribution network through the use of data to enhance the profitable and sustainable growth of Pernod Ricard, the company explains in a press release. morning.

The Quadient reported sales of € 253 million in the first quarter of 2022, an increase of 2.5% compared to the first quarter of 2021. On an organic basis, sales decreased by 0.6%. “The first quarter was largely in line with our expectations with good underlying performance in each of our three solutions, despite a high basis for comparison,” said Geoffrey Godet, Quadient’s general manager.

Riber won an order for two MBE 6000 production systems worth several million euros, as well as options for four more systems. The industrial customer ordered two MBE 6000 systems for the production of semiconductor materials for electronic devices. These machines will be delivered in 2022. This significant order in the company’s history comes with an option for 4 additional MBE 6000 systems, underlined by a specialist in molecular beam epitaxy (MBE) equipment for industry.

The FDA has approved Sanofi’s Dupixent (dupilumab) for the treatment of children aged 6 months to 5 years with moderate to severe atopic dermatitis that is not controlled with or recommended for topical prescription drugs. The European Medicines Agency is currently assessing the submission of regulatory measures for the same age group, and further submissions to regulators are underway in different countries.

Schneider Electric has entered into an agreement with Watlow Electric Manufacturing Company, an American manufacturer of complete industrial heating systems, to sell its Eurotherm business. With approximately 650 employees, Eurotherm is a global provider of temperature and energy measurement and control solutions and is currently integrated into the activities of the French company’s Industrial Automation, a leader in the digital transformation of energy management and industrial automation.

For the financial year 2021/2022, which ended at the end of March, SII generated a net result, the group’s share, of EUR 59.4 million, multiplied by 2.4. The operating result multiplied by 2.3 to 79.07 million euros, which represents a margin of 9.54%, an improvement of 4.24 points. It has thus reached a level that has not been matched for more than 15 years.

The semiconductor manufacturer will publish its annual results.

AOF 2022

Leave a Comment